MS
DGX icon

Maven Securities’s Quest Diagnostics DGX Stock Holding History

Maven Securities’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,931
Closed -$517K – 986
2023
Q3 		$479K Buy
+3,931
New +$524K 0.01% 824
2018
Q4 		– Sell
-3,852
Closed -$414K – 110
2018
Q3 		$414K Buy
+3,852
New +$422K 0.15% 104

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Maven Securities's DGX Position: Q4 2023 in Review

Maven Securities sold out of Quest Diagnostics (DGX) in Q4 2023, closing a stake of 3,931 shares — an estimated $517K sold.

Maven Securities first reported a position in DGX in Q3 2018 and held it in 2 quarters. The position peaked at $479K in Q3 2023. 826 funds tracked by Wall St. Rank hold DGX as of Q4 2023.

  • Maven Securities reported no remaining Quest Diagnostics position as of Q4 2023 after selling out during the quarter.
  • Maven Securities sold 3,931 Quest Diagnostics shares in Q4 2023, an estimated $517K.
  • Maven Securities first reported a position in Quest Diagnostics in Q3 2018 and held it in 2 quarters.
  • Maven Securities's Quest Diagnostics position peaked at $479K in Q3 2023.
  • 826 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.

Based on Maven Securities's 13F filing for Q4 2023, filed 12 Feb 2024.